San Diego’s Illumina is the world leader in gene sequencing technology — the ability to read and record DNA. Now, the billion ...

Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that incorporate the tech and chemistry used by its largest, top-of-the-line machines.

Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...

Government-backed population genomics projects escalate demand, while AI and long-read sequencing tech enhance data analysis ...

The market for whole genome and exome sequencing is set to grow significantly, driven by decreasing sequencing costs and a ...

Illumina, a San Diego-based genome sequencing provider, signed a long-term lease for a 316,000-square-foot complex less than one mile from its headquarters, The San Diego Union-Tribune reports.

Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA sequencing and array-based technologies, to provide Illumina sequencing instruments and related prod ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...

New Delhi: The escalating US-China tariff war has ratcheted up to enter the field of biotechnology and science. For the first time, China has put American genome-sequencing equipment manufacturer ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...